Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection.

  • Cardiovascular Research Unit
January 21, 2020 By:
  • Kura B
  • Kalocayova B
  • Devaux Y
  • Bartekova M.

The interest in non-coding RNAs, which started more than a decade ago, has still not weakened. A wealth of experimental and clinical studies has suggested the potential of non-coding RNAs, especially the short-sized microRNAs (miRs), to be used as the new generation of therapeutic targets and biomarkers of cardiovascular disease, an ever-growing public health issue in the modern world. Among the hundreds of miRs characterized so far, microRNA-1 (miR-1) and microRNA-21 (miR-21) have received some attention and have been associated with cardiac injury and cardioprotection. In this review article, we summarize the current knowledge of the function of these two miRs in the heart, their association with cardiac injury, and their potential cardioprotective roles and biomarker value. While this field has already been extensively studied, much remains to be done before research findings can be translated into clinical application for patient's benefit.

2020 Jan. Int J Mol Sci.21(3):E700.
Other information